Frederick J Kohlhapp Selected Research

Therapeutics

1/2021	Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade.
1/2017	Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frederick J Kohlhapp Research Topics

Disease

13	Neoplasms (Cancer) 04/2022 - 02/2011
6	Melanoma (Melanoma, Malignant) 04/2022 - 03/2011
4	Infections 01/2020 - 02/2014
2	Human Influenza (Influenza) 01/2020 - 10/2016
2	Experimental Melanoma 01/2015 - 03/2011
2	Vitiligo 02/2013 - 12/2011
1	Carcinogenesis 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016
1	Communicable Diseases (Infectious Diseases) 02/2014
1	Inflammation (Inflammations) 02/2014

Drug/Important Bio-Agent (IBA)

3	LigandsIBA 11/2014 - 11/2011
2	VaccinesIBA 01/2020 - 02/2014
2	Interleukin-2 (IL2)IBA 01/2017 - 01/2015
2	AntigensIBA 02/2014 - 12/2011
2	DNA (Deoxyribonucleic Acid)IBA 02/2013 - 03/2011
1	Immune Checkpoint InhibitorsIBA 04/2022
1	16S Ribosomal RNAIBA 04/2022
1	venetoclaxIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020
1	SqualeneIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2017
1	Programmed Cell Death 1 ReceptorIBA 10/2016
1	talimogene laherparepvecIBA 03/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2016
1	Protein Kinases (Protein Kinase)IBA 03/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2016
1	CTLA-4 AntigenIBA 01/2015
1	Fas Ligand Protein (Fas Ligand)IBA 11/2014
1	Death Domain ReceptorsIBA 11/2014
1	Vaccine AdjuvantsIBA 02/2014
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 02/2014
1	Peptides (Polypeptides)IBA 02/2014
1	OvalbuminIBA 02/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2013
1	interferon tauIBA 12/2011
1	NK Cell Lectin-Like Receptor Subfamily KIBA 12/2011
1	tyrosinase-related protein-1IBA 12/2011
1	Transcription Factors (Transcription Factor)IBA 03/2011

Therapy/Procedure

7	Immunotherapy 04/2022 - 02/2011
2	Therapeutics 01/2021 - 01/2017
1	Intramuscular Injections 01/2020
1	Contraindications 01/2020
1	Drug Therapy (Chemotherapy) 01/2017
1	Perioperative Period 03/2011